Investigation of the Effect of Nomophobia on Musculoskeletal System and Sleep

December 6, 2023 updated by: Dr. Öğr. Üyesi Ömer Şevgin, Uskudar University
The aim of this study; Investigation of the effects on the musculoskeletal system and sleep by determining the nomophobia levels of individuals between the ages of 18-25.

Study Overview

Status

Completed

Conditions

Intervention / Treatment

Detailed Description

The research was planned as a quantitative research. Data collection was done online.

The scales and forms used are as follows:

  1. Demographic Information Form
  2. Nomophobia Scale
  3. Cornell Musculoskeletal Disorder Questionnaire
  4. Smart phone Addiction Scale
  5. Pittsburgh Sleep Quality Index
  6. International Physical Activity Survey
  7. McGill Melzack Pain Questionnaire

Questionnaires will be sent to the participants online by invitation. Participants will be asked to participate in the study by reaching them through social media, mail or mobile phone applications. The data obtained will be analyzed statistically.

Study Type

Observational

Enrollment (Actual)

200

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Locations

      • Istanbul, Turkey
        • Uskudar University
        • Contact:
          • Ömer ŞEVGİN

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult

Accepts Healthy Volunteers

Yes

Sampling Method

Non-Probability Sample

Study Population

people with whom we were able to create the survey and who met the inclusion criteria

Description

Inclusion Criteria:

  • To have accepted the voluntary consent form that requires participation in the survey study.
  • Being a smart phone user

Exclusion Criteria:

  • Not accepting the volunteer consent form
  • Having undergone previous surgery
  • Being on antidepressants.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
1.Group
Nomophobia Level:none

The scales and forms used are respectively:

  1. Demographic Information Form
  2. Nomophobia Scale
  3. Cornell Musculoskeletal Disorder Questionnaire
  4. Smart phone Addiction Scale
  5. Pittsburgh Sleep Quality Index
  6. International Physical Activity Survey
  7. McGill Melzack Pain Questionnaire
2.Group
Nomophobia Level: mild

The scales and forms used are respectively:

  1. Demographic Information Form
  2. Nomophobia Scale
  3. Cornell Musculoskeletal Disorder Questionnaire
  4. Smart phone Addiction Scale
  5. Pittsburgh Sleep Quality Index
  6. International Physical Activity Survey
  7. McGill Melzack Pain Questionnaire
3.Group
Nomophobia Level: medium

The scales and forms used are respectively:

  1. Demographic Information Form
  2. Nomophobia Scale
  3. Cornell Musculoskeletal Disorder Questionnaire
  4. Smart phone Addiction Scale
  5. Pittsburgh Sleep Quality Index
  6. International Physical Activity Survey
  7. McGill Melzack Pain Questionnaire
4.Group
Nomophobia Level: extreme

The scales and forms used are respectively:

  1. Demographic Information Form
  2. Nomophobia Scale
  3. Cornell Musculoskeletal Disorder Questionnaire
  4. Smart phone Addiction Scale
  5. Pittsburgh Sleep Quality Index
  6. International Physical Activity Survey
  7. McGill Melzack Pain Questionnaire

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Nomophobia Scale
Time Frame: 2 days
The Nomophobia Scale was itemized according to a 7-point Likert type. Out of 20 items in total consists of. The scale has four sub-dimensions: Lack of Access to Information (4 items), Losing Connection (5 items), Inability to Communicate (6 items), and Comfort Inability to feel (5 items).
2 days
Cornell Musculoskeletal Disorder Questionnaire
Time Frame: 2 days
The questionnaire was conducted in 11 body regions (neck, right and left shoulder, upper arm, forearm and wrist, back and waist region) includes questions about the frequency of musculoskeletal disorders (pain/pain/discomfort), the severity of these disorders, and whether they interfere with work.
2 days
Smart phone Addiction Scale
Time Frame: 2 days
It is a scale developed to measure the risk of smart phone addiction, consisting of 10 items and evaluated with a six-point Likert scale. Scale items were scored from 1 to 6. Scale scores range from 10 to 60. As the score obtained from the test increases, it is considered that the risk for addiction increases.
2 days
Pittsburgh Sleep Quality Index
Time Frame: 2 days
It is a 19-item self-report scale that evaluates sleep quality and impairment over the past month. It consists of 24 questions, 19 questions are self-report questions, 5 questions are questions to be answered by the spouse or roommate. The 18 scored questions of the scale consist of 7 components. Subjective Sleep Quality, Sleep Latency, Sleep Duration, Habitual Sleep Efficiency, Sleep Disorder, Sleeping Drug Use and Daytime Dysfunction. Each component is evaluated over 0-3 points. The total score of the 7 components gives the scale total score. The total score ranges from 0 to 21. A total score greater than 5 indicates "poor sleep quality".
2 days
International Physical Activity Questionnaire Short Form
Time Frame: 2 days

The questionnaire consisting of seven questions including the activities of the last seven days was prepared by the individuals themselves.

self-applicable and provides information about the time people spend in moderate to vigorous activities

2 days
McGill Melzack Pain Questionnaire
Time Frame: 2 days
Pain Questionnaire consists of four parts. With the McGill Melzack Pain Questionnaire, the location of the pain, the feeling it creates in the individual, its relationship with time, its severity and the level of livable pain for the individual are determined.
2 days

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Study Chair: Melek ÖZCAN, Uskudar University

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

September 1, 2023

Primary Completion (Actual)

October 2, 2023

Study Completion (Actual)

December 6, 2023

Study Registration Dates

First Submitted

August 17, 2023

First Submitted That Met QC Criteria

August 17, 2023

First Posted (Actual)

August 23, 2023

Study Record Updates

Last Update Posted (Estimated)

December 7, 2023

Last Update Submitted That Met QC Criteria

December 6, 2023

Last Verified

December 1, 2023

More Information

Terms related to this study

Keywords

Other Study ID Numbers

  • Uskudar55

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Dependence

Clinical Trials on Survey

3
Subscribe